Back to available technologies

A novel method for augmenting the effect SSRIs

A method of treating a subject for a serotonergic neurotransmission dysregulation disorder, comprises administering the subject a serotonin enhancer (e.g., a serotonin reuptake inhibitor) in an amount effective to treat the disorder; and concurrently administering the subject 5-hydroxytryptophan in an amount effective to enhance the activity of the serotonin enahancer, (e.g., serotonin reuptake inhibitor). In preferred embodiments the disorder is depression, anxiety, or substance abuse.

Duke File (IDF) Number

T-002430

Inventor(s)

  • Krishnan, K. Ranga
  • Beaulieu, Martin
  • Caron, Marc G
  • Gainetdinov, Raul
  • Sotnikova, Tatiana
  • Zhang, Xiaodong

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.